Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)

Foresee Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,039	11,995	13,062	10,797	14,047	10,474
Market Cap Growth	-12.68%	-8.16%	20.98%	-23.14%	34.12%	79.10%
Enterprise Value	12,423	11,645	11,754	9,869	12,654	10,323
Last Close Price	84.20	77.50	96.18	90.37	118.16	88.59
Forward PE	-	-	-	-	-	18.90
PS Ratio	29.45	28.65	66.97	35.81	62.15	45.45
PB Ratio	13.42	7.50	10.50	11.86	10.64	5.73
P/TBV Ratio	15.21	8.10	11.69	14.03	12.06	6.47
EV/Sales Ratio	28.06	27.81	60.27	32.73	55.98	44.80
Debt / Equity Ratio	0.26	0.16	0.18	0.05	0.01	0.07
Asset Turnover	0.28	0.21	0.12	0.21	0.12	0.15
Inventory Turnover	1.34	1.15	0.54	0.25	1.73	1.54
Quick Ratio	2.22	3.63	2.65	5.54	17.12	13.45
Current Ratio	2.92	4.62	3.38	7.08	17.51	13.87
Return on Equity (ROE)	-143.98%	-76.04%	-96.17%	-42.38%	-36.15%	-37.48%
Return on Assets (ROA)	-55.10%	-33.57%	-39.79%	-19.92%	-18.00%	-19.49%
Return on Capital (ROIC)	-71.26%	-40.51%	-51.95%	-25.64%	-20.43%	-21.13%
Earnings Yield	-10.89%	-9.01%	-7.93%	-4.38%	-4.05%	-4.88%
FCF Yield	-11.37%	-11.03%	-7.15%	-2.70%	-1.57%	-6.57%
Buyback Yield / Dilution	-7.70%	-7.89%	-7.82%	-0.57%	-15.74%	-5.71%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.